Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide

The New England Journal of Medicine
N L BenowitzL Yu

Abstract

In the hope of reducing the adverse health consequences of smoking, physicians frequently advise their patients who cannot quit to smoke fewer cigarettes. Habitual smokers may compensate for the reduced number of cigarettes, however, by taking in more smoke per cigarette. We measured the intake of tar (estimated as mutagenic activity of the urine), nicotine, and carbon monoxide during short-term cigarette restriction. With a reduction from an average of 37 cigarettes to an average of 5 cigarettes per day, the intake of tobacco toxins per cigarette increased roughly threefold and daily exposure to tar and carbon monoxide declined only 50 percent. We conclude that smoking fewer cigarettes may reduce exposure to toxins and related adverse health consequences. However, consistent with a tendency to maintain intake of nicotine, the magnitude of the benefit is much less than expected. Whether "oversmoking" persists during long-term restriction of cigarettes requires further investigation.

References

Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·E Yamasaki, B N Ames
Jul 18, 1981·British Medical Journal·R I HerningA H Mines
Jun 26, 1982·British Medical Journal·D O Ho-YenW F Walker
Feb 24, 1983·The New England Journal of Medicine·D W KaufmanS Shapiro
Jul 21, 1983·The New England Journal of Medicine·N L BenowitzA L Osman
Apr 5, 1980·British Medical Journal·M A RussellC Feyerabend
Mar 15, 1958·Journal of the American Medical Association·E C Hammond, D Horn

❮ Previous
Next ❯

Citations

Jan 1, 1990·International Archives of Occupational and Environmental Health·G SchererF Adlkofer
Jan 1, 1989·Psychopharmacology·S Shiffman
Jan 1, 1992·Psychopharmacology·S ShiffmanG O'Brien
Aug 1, 1995·Psychopharmacology·K J Schuh, M L Stitzer
Oct 16, 2009·Psychopharmacology·Chris R E CogginsChristian Heidbreder
Oct 1, 1987·Pharmacology, Biochemistry, and Behavior·J E Rose, F Behm
Apr 1, 1992·Pharmacology, Biochemistry, and Behavior·M L StitzerL J Felch
Jun 1, 1989·Biological Psychology·P M CinciripiniH B Gjika
Mar 1, 1996·Addictive Behaviors·L H BrauerS Shiffman
Jan 30, 2004·The American Journal of Medicine·Neal L Benowitz
May 1, 1997·Obstetrics and Gynecology·R H Secker-WalkerP B Mead
Jan 1, 1989·Experimental Pathology·G SchererF Adlkofer
Jun 7, 2003·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Shu-Hong ZhuSharon Cummins
Jan 17, 2007·The Pharmacogenomics Journal·M K Ho, R F Tyndale
Jul 14, 1994·The New England Journal of Medicine·N L Benowitz, J E Henningfield
Apr 5, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Philip TønnesenFredrik Nilsson
Jun 13, 2006·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Dorothy K HatsukamiStephen S Hecht
Nov 30, 2006·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·John R Hughes, Matthew J Carpenter
Mar 4, 2011·American Journal of Epidemiology·Wael K Al-Delaimy, Walter C Willett
Sep 10, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H ItoK Matsuo
Apr 5, 2012·Journal of Analytical Toxicology·Stephanie L YousoBrian A Logue
Aug 19, 1999·Journal of the National Cancer Institute·A W Bergen, N Caporaso
Oct 3, 2002·Journal of the National Cancer Institute·Peter G Shields
Jan 22, 2004·Journal of the National Cancer Institute·Stephen S HechtDorothy K Hatsukami
Jan 22, 2004·Journal of the National Cancer Institute·Scott J Leischow, Mirjana V Djordjevic
Feb 28, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Corinne G Husten
Feb 28, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·John P PierceKaren Messer
Feb 28, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Dina N K BoulosMostafa K Mohamed
Feb 1, 1990·British Journal of Addiction·L T Kozlowski, R G Ferrence
Aug 1, 1992·British Journal of Addiction·J NørregaardU Säwe
Nov 1, 1994·Addiction·P Hajek
Mar 5, 1994·BMJ : British Medical Journal·J T Powell, R M Greenhalgh
Dec 1, 1989·The American Review of Respiratory Disease·F A HerbertR L Hackett
Aug 1, 1993·The American Review of Respiratory Disease·D B CoultasJ M Samet
Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·J M Samet, P Lange

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
R D HurtA M Jeffrey
The New England Journal of Medicine
N L BenowitzA L Osman
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
A J Farkas
© 2021 Meta ULC. All rights reserved